The role of anti-PD-1/PD-L1 monotherapy as first-line treatment of metastatic NSCLC without targetable mutations and PD-L1 TPS 1–49%
@article{PCM5915, author = {Arpeet T. Shah and Joel W. Neal}, title = {The role of anti-PD-1/PD-L1 monotherapy as first-line treatment of metastatic NSCLC without targetable mutations and PD-L1 TPS 1–49%}, journal = {Precision Cancer Medicine}, volume = {4}, number = {0}, year = {2020}, keywords = {}, abstract = {}, issn = {2617-2216}, url = {https://pcm.amegroups.org/article/view/5915} }